In February, Trump directed federal agencies to stop funding public benefits for foreign nationals living illegally in the U.S.

The “friend of the court” filing, by a group of 27 former governors – including former Massachusetts Governors Deval Patrick ...

The Trump administration on Thursday announced its newest pharmaceutical agreement under its Most Favored Nation (MFN) policy, striking deals with Novo Nordisk and Eli Lilly to sell their GLP-1 ...

In their competition for rural health care dollars from a new federal fund, states are seeking money to bolster emergency services, address chronic diseases, and recruit and train more doctors and ...

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

I call on Attorney General Dave Yost to join the lawsuits filed by his fellow Attorneys General against the federal government’s refusal to disburse SNAP benefits beyond Nov. 1. For an agency of the ...

Presented by the Coalition to Strengthen America’s Healthcare — State Medicaid programs that choose to participate in the model will be able to purchase drugs included in the pilot at prices ...

On October 31, 2025, the Centers for Medicare & Medicaid Services (CMS) issued the physician fee schedule (PFS) final rule for calendar year (CY) ...

The agreement will make Wegovy and Zepbound available to some Medicare enrollees for $245 per month, and starter doses of pill versions, once approved, for $149 monthly.

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

The model aims to deliver primary care locally while leveraging "hubs" that offer specialty medical services to neighboring ...

Picking the right health insurance that provides the right level of coverage at an affordable price can be an overwhelming ...